PN50ME significantly suppressed dyslipidemia, steatosis and hepatocyte ballooning, insulin resistance, oxidative stress, hepatocyte injury, inflammation, and obesity in a rat model of HFD-induced NAFLD. The gene discussed is INS; the disease is obesity disorder.